Krsnaa Diagnostics · NSE: KRSNAA · BSE: 543328
Q2 FY22 results · Jul–Sep 2021
Krsnaa Diagnostics reported revenue from operations of ₹108.26 crore and net profit of ₹12.53 crore for Q2 FY22 (Jul–Sep 2021), on a consolidated basis.
| Item | Q2 FY22 | Q2 FY21 | YoY | Q1 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 108.26 | — | — | — | — |
| Other income | 3.23 | — | — | — | — |
| Total income | 111.49 | — | — | — | — |
| Profit before tax | 16.62 | — | — | — | — |
| Net profit for the period | 12.53 | — | — | — | — |
| EPS, basic (₹) | 4.51 | — | — | — | — |
| Net margin (%) | 11.6 | — | — |
| Item | Q2 FY22 | Q2 FY21 | YoY | Q1 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 108.26 | — | — | — | — |
| Other income | 3.23 | — | — | — | — |
| Total income | 111.49 | — | — | — | — |
| Profit before tax | 16.63 | — | — | — | — |
| Net profit for the period | 12.54 | — | — | — | — |
| EPS, basic (₹) | 4.51 | — | — | — | — |
| Net margin (%) | 11.6 | — | — |
Consolidated
- Filed with BSE
- 12 Oct 2021, 13:00 IST
- Board meeting
- 11 Oct 2021
- Period
- 01 Jul 2021 to 30 Sep 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 12 Oct 2021, 13:00 IST
- Board meeting
- 11 Oct 2021
- Period
- 01 Jul 2021 to 30 Sep 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE